Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...

Armed with preliminary clinical data, US start-up Alzheon has raised $10 million to help take its oral Alzheimer's therapy ALZ-801 into a phase II/III trial. The financing means that Alzheon can ...

Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments. Skip to main content. Your source for the latest research news.